股神经导管改善全髋关节置换术治疗髋部骨折患者的居家转归与疼痛
研究纳入29例连续老年髋部骨折行全髋关节置换术患者,15例接受标准镇痛,14例接受超声引导股神经导管置入。结果显示股神经导管组出院回家比例更高(43% vs 7%,P=0.023),术前、术后第1天及第2天疼痛评分更低,术前吗啡当量用量减少61%(P=0.007),阿片相关副作用更少(7% vs 47%,P=0.035)。作者基于此推荐围手术期常规使用连续股神经导管。
要点
- 股神经导管组出院回家比例43%,标准镇痛组7%(P=0.023)。
- 股神经导管组术前疼痛评分更低(P<0.0001),术后第1天(P=0.005)和第2天(P=0.037)也更低。
- 股神经导管组术前吗啡当量用量减少61%(P=0.007),阿片相关副作用7% vs 47%(P=0.035)。
核心结论
- 股神经导管组出院回家更频繁,每日平均患者报告的疼痛评分、术前阿片用量及阿片相关副作用均降低。
- 基于这些数据,作者推荐在髋部骨折行全髋关节置换术的患者中常规使用围手术期连续股神经导管。
研究设计与样本
- 连续纳入29例老年髋部骨折患者(22女/7男)行全髋关节置换术,平均随访8.3个月(6周至39个月)。
- 15例接受标准镇痛,14例在影像学确认髋部骨折后接受超声引导股神经导管置入。
- 记录术后6周内发生的所有并发症和再入院。
主要发现
- 股神经导管组出院回家比例43%,标准镇痛组7%(P=0.023)。
- 股神经导管组术前平均疼痛评分低于标准镇痛组(P<0.0001),术后第1天(P=0.005)和术后第2天(P=0.037)也低于标准镇痛组。
- 术前股神经导管组吗啡当量用量较标准镇痛组减少61%(P=0.007)。
- 股神经导管组阿片相关副作用发生率为7%,标准镇痛组为47%(P=0.035)。
临床怎么用
- 作者基于数据推荐在髋部骨折行全髋关节置换术的患者中常规使用围手术期连续股神经导管。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Opioids have been the mainstay of treatment in the physiologically young geriatric hip fracture patient undergoing total hip arthroplasty (THA). However opioid-related side effects increase morbidity. Regional anesthesia may provide better analgesia, while decreasing opioid-related side effects. The goal of this study was to examine the effect of perioperative continuous femoral nerve blockade with regards to pain scores, opioid-related side effects and posthospital disposition in hip fracture patients undergoing THA. METHODS: Twenty-nine consecutive geriatric hip fracture patients (22 women/7 men) underwent THA. Average follow-up was 8.3 months (6 weeks-39 months). Fifteen patients were treated with standard analgesia (SA). Fourteen patients received an ultrasound-guided insertion of a femoral nerve catheter after radiographic confirmation of a hip fracture. All complications and readmissions that occurred within 6 weeks of surgery were noted. RESULTS: Continuous femoral nerve catheter (CFNC) patients were discharged home more frequently than SA patients (43% for CFNC vs 7% for SA; P = .023). CFNC patients reported lower average pain scores preoperatively (P < .0001), on postoperative day 1 (P = .005) and postoperative day 2 (P = .037). Preoperatively, CFNC patients required 61% less morphine equivalent (P = .007). CFNC patients had a lower rate of opioid-related side effects compared with SA patients (7% vs 47%; P = .035). CONCLUSION: CFNC patients were discharged to home more frequently. Use of a CFNC decreased daily average patient-reported pain scores, preoperative opioid usage, and opioid-related side effects after THA for hip fracture. Based on these data, we recommend routine use of perioperative CFNC in hip fracture patients undergoing THA.
引用
- Arsoy D, Huddleston JI, Amanatullah DF, et al. Femoral Nerve Catheters Improve Home Disposition and Pain in Hip Fracture Patients Treated With Total Hip Arthroplasty. J Arthroplasty. 2017. PMID: 28641968. doi:10.1016/j.arth.2017.05.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。